Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04650256 · ClinicalTrials.gov registry record · NA
Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences
A NA study of Skin Toxicity, sponsored by University of Miami.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT04650256 is a NA study of Skin Toxicity that is actively recruiting participants, run by University of Miami. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04650256, a NA study of Skin Toxicity, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to study a Chinese herbal Complementary and Alternative Medicine (CAM) product for the temporary relief of pain and itching after radiotherapy (RT). This is an over-the-counter product with 1% menthol as an active ingredient.
Conditions Studied
Interventions
- OTHER Complementary and alternative medicine (CAM)
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04650256
The ClinicalTrials.gov registry entry for NCT04650256 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Skin Toxicity appearing as the primary indexed condition, and to 1 intervention - of which Complementary and alternative medicine (CAM) is the first listed.
NCT04650256 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT04650256 about?
NCT04650256 is a clinical study titled "Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences". The purpose of this research is to study a Chinese herbal Complementary and Alternative Medicine (CAM) product for the temporary relief of pain and itching after radiotherapy (RT). This is an over-the-counter product with 1% menthol as an active ingredient.
What is the current status of trial NCT04650256?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2021-07-01. Estimated completion is 2025-12-31.
What conditions does trial NCT04650256 study?
This clinical trial studies the following conditions: Skin Toxicity.
What interventions are being tested in trial NCT04650256?
The interventions under investigation include: Complementary and alternative medicine (CAM) (OTHER).
Who is sponsoring clinical trial NCT04650256?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04650256 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Toxicity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.